Tag: Form 8-K
Social Leverage Acquisition Corp I and W3BCLOUD Announce Revised Business Combination Transaction Terms
MicroStrategy Acquires More Bitcoin Amid Market Recovery
Bitcoin Whale MicroStrategy Repays Silvergate Loan And Buys Another $150 Million Worth Of BTC
MicroStrategy’s Bold $150M BTC Buy Fuels Crypto Debate
WisdomTree Adopts Limited Duration Stockholder Rights Plan
Verisign Reports Fourth Quarter and Full Year 2022 Results
TeraWulf Announces Beneficial Debt Modifications and Approximately $32 Million of New Equity Proceeds
Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics
Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement
Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to $45 million loan facility and conversion of existing convertible notes into shares and new term loan facility ROSARIO, Argentina & RALEIGH, N.C.–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (Bioceres) and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced today that […]
The post Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement appeared first on Fintech News.
SmartMetric Adopts A “Green” Rechargeable Battery For Its Biometric Self Powered Biometric Credit Cards
NEW YORK–(BUSINESS WIRE)–#americanexpress–SmartMetric, Inc. (OTCQB: SMME): The SmartMetric biometric credit card that has an inbuilt rechargeable battery to power the cards fingerprint recognition processor is powered by a green, environmentally safe miniature internal battery. “The battery we are using is what we call a non-volatile miniature battery that can even be cut with scissors without […]
The post SmartMetric Adopts A “Green” Rechargeable Battery For Its Biometric Self Powered Biometric Credit Cards appeared first on Fintech News.
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
Nano Precision Medical’s lead program (NPM-119) is a tiny subdermal implant of a GLP-1 receptor agonist to treat patients with Type 2 diabetes Second Sight will issue 134M shares to acquire full ownership of Nano Precision Medical. Second Sight shareholders will own ~23% of the combined company. Second Sight shareholders join NPM shareholders, including AstraZeneca […]
The post Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company appeared first on Fintech News.